A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer
Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/cji.0000000000000012
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)